Research summary
A two-period review of AXP revenue, profitability and cash conversion; reported revenue growth was 6.39%.
Period comparison
FY2025 ended 2025-12-31; the prior observation ended 2024-12-31. Revenue moved from USD 38.825 billion to USD 41.304 billion. These are annual periods, not quarterly earnings or trailing-twelve-month estimates.
Earnings bridge
Net income moved from USD 10.129 billion to USD 10.833 billion. Operating income moved from not available to not available. Net margin moved from 26.09% to 26.23%. A margin change identifies an outcome; its causes require management discussion and footnotes.
Cash-flow cross-check
Operating cash flow was USD 14.050 billion in the earlier period and USD 18.428 billion in the later period. Selected free cash flow was USD 12.139 billion and USD 16.003 billion, respectively. Working-capital timing can cause earnings and cash to diverge.
Interpretation and limits
A rise in reported revenue does not by itself identify organic growth. A difference in EPS can reflect share-count changes as well as operating performance. No causal claim is made from these aggregate figures.
Valuation context
An earnings comparison provides a historical denominator, not a price target. A dated market price is deliberately absent from this static release.
What to monitor
Net interest income, credit provisions, fee income, underwriting results and capital adequacy.
Risks and uncertainties
Credit losses, deposit pricing, reserve assumptions, market liquidity and regulatory capital.
Sources & dates
- SEC annual filing · 2025-12-31 ↗Source date 2026-02-06
- SEC annual filing · 2024-12-31 ↗Source date 2026-02-06
- SEC annual filing · 2023-12-31 ↗Source date 2026-02-06
- SEC annual filing · 2022-12-31 ↗Source date 2025-02-07
- SEC issuer record ↗Source date 2026-09-18